Analysts expect that Avantor, Inc. (NYSE:AVTR) will report sales of $1.90 billion for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Avantor’s earnings. The highest sales estimate is $1.95 billion and the lowest is $1.87 billion. Avantor posted sales of $1.79 billion during the same quarter last year, which indicates a positive year over year growth rate of 6.1%. The company is scheduled to announce its next earnings results on Wednesday, February 2nd.
On average, analysts expect that Avantor will report full year sales of $7.38 billion for the current year, with estimates ranging from $7.35 billion to $7.43 billion. For the next year, analysts expect that the firm will post sales of $8.03 billion, with estimates ranging from $7.76 billion to $8.25 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Avantor.
Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, October 27th. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.32 by $0.03. Avantor had a return on equity of 39.88% and a net margin of 7.07%. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period last year, the business posted $0.24 EPS. Avantor’s quarterly revenue was up 14.3% on a year-over-year basis.
In other Avantor news, EVP Frederic Vanderhaegen sold 80,000 shares of the firm’s stock in a transaction dated Friday, November 12th. The stock was sold at an average price of $38.25, for a total transaction of $3,060,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Christophe Couturier sold 10,184 shares of the stock in a transaction dated Monday, December 27th. The stock was sold at an average price of $41.63, for a total transaction of $423,959.92. The disclosure for this sale can be found here. Insiders sold 405,290 shares of company stock worth $16,117,667 in the last three months. 2.00% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its position in shares of Avantor by 1.7% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 70,255,024 shares of the company’s stock valued at $2,494,756,000 after acquiring an additional 1,164,442 shares during the period. Vanguard Group Inc. lifted its position in shares of Avantor by 1.0% during the 2nd quarter. Vanguard Group Inc. now owns 48,635,241 shares of the company’s stock valued at $1,727,037,000 after acquiring an additional 496,583 shares during the period. BlackRock Inc. lifted its position in shares of Avantor by 8.3% during the 3rd quarter. BlackRock Inc. now owns 38,224,314 shares of the company’s stock valued at $1,563,371,000 after acquiring an additional 2,937,760 shares during the period. Boston Partners lifted its position in shares of Avantor by 17.2% during the 2nd quarter. Boston Partners now owns 21,234,609 shares of the company’s stock valued at $754,082,000 after acquiring an additional 3,120,341 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of Avantor by 0.8% during the 3rd quarter. American Century Companies Inc. now owns 15,717,049 shares of the company’s stock worth $642,827,000 after purchasing an additional 117,325 shares in the last quarter. Institutional investors and hedge funds own 90.81% of the company’s stock.
Shares of AVTR stock traded up $0.21 on Friday, hitting $37.71. The company had a trading volume of 3,767,616 shares, compared to its average volume of 4,729,052. The firm has a market cap of $22.98 billion, a P/E ratio of 47.75, a price-to-earnings-growth ratio of 0.87 and a beta of 1.60. The company has a 50-day moving average price of $39.43 and a 200-day moving average price of $39.11. The company has a quick ratio of 2.06, a current ratio of 2.70 and a debt-to-equity ratio of 1.79. Avantor has a twelve month low of $26.14 and a twelve month high of $44.37.
Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates through the following segments: the Americas, Europe, and AMEA.
Featured Story: What is the Shanghai Stock Exchange Composite Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.